Rebirth Flyer | Regeneration (Biology) | Regenerative Medicine

of 8

Please download to get full document.

View again

All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
8 pages
0 downs
Regenerative Biology to Regenerative Therapy, Germany
  From  RegenerativeBiology  to  ReconstructiveTherapy  Hannover Medical School & Partners Cluster of Excellence  The goal o the Excellence Initiativeis to strengthen cutting-edge researchin Germany and to improve its inter-national competitiveness. Outstan-ding projects are unded as Clusterso Excellence which ocus the researchpotential at university locations in Germany and, hence, streng-then their international visibility.With the enthusiastic support o six important partner institu-tions, Hannover Medical School (MHH) has estab-lished a Cluster o Excellence in the area o  RegenerativeBiology andReconstruc- tiveTherapies , acronym REBIRTH. REBIRTH receives unding over a peri-od o ve years with an average bud-get o 6.5 million euros per year. REBIRTH - Optimal partner  Our programme integrates excellenttraining with innovative science and ex-perimental as well as clinical medicine.Interactive basic research projects aredesigned to identiy and evaluate cellularand molecular mediators that stimulateregeneration.We test new approaches or regenerativetherapies using novel (i possible somatic) cell sources which weengineer applying genetic, epigenetic, as well as scaold-basedprinciples. Expertise in various elds o engineering, chemistry,biophotonics and nanotechnology supports and supplements ourresearch and development.Toward patient-ocused, applied studies, the existing wide ran-ge o certied/accredited acilities or Good Practice (laboratory, The Hans Borst Center  or Heart and Stem Cell Research was unded with13.5 million euros by theBraukmann-WittenbergHeart Foundation.Since May 2008 13 o 40working groups are based in the new building. Establishing an excellentcluster   manuacturing and clinical) and close industrial collaborationswill be urther expanded. Upscaling technologies and pro-activebiosaety assessment complete our translational activities.Based upon MHH’s recent key achievements and priorities weocus on disorders o  blood (including immunity), heart , lung   (respiratory tract), liver, and pancreatic beta cells. REBIRTH - Cluster o Excellence in the area o Regenerative Biology and Reconstructive Therapies. We ocus on disorders o blood (including immunity), heart, lung (respiratory tract) and liver in a disease specic way. Human Resources Established Therapy  Area A  RegenerativeBiology ã Phylogenyã Ontogenyã Milieuã Cell Proliferationã (Epi) Genetics BloodHeartLungLiver  FunctionStemness  Area B ReconstructiveTherapy ã Tissue Engineering/  FunctionalizedImplants ã Cell Therapyã Regenerative Agents Approval Reprogramming  Differentiation  Area C ã GLP, GMP, GCPã Upscaling ã MolTox/ Pathologyã Imaging  Good practice and PharmacovigilanceClinical trials Feedback   Area D ã Education   ã Ethicsã Public Relations Disease models Cultural  Diversity Gender  Equity Thereby, REBIRTH represents an optimal partner or other dome-stic and international centres in regenerative medicine.  Rational drug design producesisoorm-specic inhibitorsthat target a novel allosteric binding site in myosin. Hannover Medical SchoolMax Planck Institute or Molecular Biomedicine, Münster  Our basic research activities in AreaA are conducted by two collaborati-ve research units that ocus on StemCell Biology  and Regeneration andOrganogenesis . Key objectives o our work programme are to obtaindeeper insights into the basic mecha-nisms o genetic and epigenetic re-programming, allowing us to developnovel pluripotent cell sources potentially derived rom postnatal tis-sues, and to control their dierentiation with subsequent robust unc-tional tests. Discovering novel therapeutic targets The eld o stem cell biology will receive a new twist by addressing thebiochemical and genetic basis that orms the “sweet surace” o stemcells, with potentially immense implicationsor their homing, migration, dieren-tiation and labeling. Furthermore,we wish to identiy key playerso organogenesis and compa-re these to the regulators o milieu-dependent regene-ration. Finally, we exploreintrinsic and extrinsic limi-tations o regeneration bystudying mechanisms o cellcycle control, senescence andageing. This work is designed todiscover novel therapeutic targetsand methods. Area A has multiple in-teractions with Area B.  Area A:RegenerativeBiology andRelatedSciences
Related Search
We Need Your Support
Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

Thanks to everyone for your continued support.

No, Thanks